Articles by Dana-Farber Cancer Institute

AI models uncover patterns across two-dimensional images of tumor samples that could help predict response to immunotherapy

Findings may drive clinical trials for potential treatment options for CH patients with high blood cancer risk

Discovery may help design drugs that prevent T-cell therapies from losing their efficacy over time

Researchers hope their work will help make genomic profiling standard of care for pediatric solid tumors

The results provide a clearer picture of how kidney tumor microenvironments change in response to immunotherapy

Dana-Farber Cancer Institute scientists have identified several features of kidney cancer tumors that influence their response to immune checkpoint inhibitor drugs

Scientists have found a rare, inherited gene mutation that raises the risk of pancreatic cancer and other malignancies